Systemic immune activation in HIV and potential therapeutic options.

about

[Key role played by the gut associated lymphoid tissue during human immunodeficiency virus infection].Effect of Probiotic Supplementation on CD4 Cell Count in HIV-Infected Patients: A Systematic Review and Meta-analysis.

P2860

Q40869409-8C2E20A7-4631-4043-A436-FFBCB7873C6E Q47571783-9139F3B8-2BB1-4CF5-9F41-455147A6EE52

P2860

Systemic immune activation in HIV and potential therapeutic options.

Item

http://www.wikidata.org/entity/Q38189500

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Systemic immune activation in HIV and potential therapeutic options.

@en

type

Item

label

Systemic immune activation in HIV and potential therapeutic options.

@en

prefLabel

Systemic immune activation in HIV and potential therapeutic options.

@en

P1476

Systemic immune activation in HIV and potential therapeutic options

@en

P2093

Bhaswati Sinha

http://www.w3.org/2001/XMLSchema#string

P2860

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

Toll-like receptors

Role of CD14 in Cellular Recognition of Bacterial Lipopolysaccharides

Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients.

Cycling of gut mucosal CD4+ T cells decreases after prolonged anti-retroviral therapy and is associated with plasma LPS levels.

Late presentation for human immunodeficiency virus care in the United States and Canada.

Toll signaling pathways in the innate immune response.

Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2.

P304

89-95

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/08923973.2014.890217

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Muni Rubens

P577

2014-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24552614

http://www.w3.org/2001/XMLSchema#string

Systemic immune activation in HIV and potential therapeutic options.

about

P2860

P2860

Systemic immune activation in HIV and potential therapeutic options.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698